ASEP Medical Holdings Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	0.24	0.02	-	-	-	0.06
Cost of Revenue	-	-	-	-	0.03	0.06
Gross Profit	0.24	0.02	-	-	-0.03	0.01
Selling, General & Admin	2.57	2.71	1.58	0.79	0	0.01
Research & Development	0.12	0.68	0.62	0.08	-	-
Operating Expenses	4.63	6.63	4.6	2.11	0	0.01
Operating Income	-4.39	-6.61	-4.6	-2.11	-0.03	-0
Interest Expense	-	-0	-0	-0.11	-	-
Currency Exchange Gain (Loss)	0	-0	-0	-0	-	-
Other Non Operating Income (Expenses)	-0.54	-1.11	-0.85	-0.34	-	-
EBT Excluding Unusual Items	-5.08	-7.73	-5.45	-2.56	-0.03	-0
Merger & Restructuring Charges	-	-1.28	-0.4	-	-	-
Other Unusual Items	-0.43	-0.43	-	-	-	-
Pretax Income	-5.51	-9.43	-5.85	-2.56	-0.03	-0
Income Tax Expense	-	-	-0.09	-	-	-
Earnings From Continuing Operations	-5.51	-9.43	-5.76	-2.56	-0.03	-0
Minority Interest in Earnings	0.87	1.2	1.23	0.16	-	-
Net Income	-4.64	-8.23	-4.52	-2.4	-0.03	-0
Net Income to Common	-4.64	-8.23	-4.52	-2.4	-0.03	-0
Shares Outstanding (Basic)	7	6	6	2	-	-
Shares Outstanding (Diluted)	7	6	6	2	-	-
Shares Change (YoY)	23.19%	10.75%	163.12%	-	-	-
EPS (Basic)	-0.63	-1.32	-0.81	-1.12	-	-
EPS (Diluted)	-0.63	-1.32	-0.81	-1.12	-	-
Free Cash Flow	-1.11	-2.71	-3.61	-1.37	-0.02	-0.05
Free Cash Flow Per Share	-0.15	-0.44	-0.64	-0.64	-	-
Gross Margin	100.00%	100.00%	-	-	-	10.07%
Operating Margin	-1797.77%	-31271.78%	-	-	-	-0.58%
Profit Margin	-1900.29%	-38918.30%	-	-	-	-0.58%
Free Cash Flow Margin	-455.82%	-12837.39%	-	-	-	-78.40%
EBITDA	-3.11	-5.33	-3.33	-1.92	-	-
D&A For EBITDA	1.28	1.28	1.27	0.19	-	-
EBIT	-4.39	-6.61	-4.6	-2.11	-0.03	-0
EBIT Margin	-	-	-	-	-	-0.58%
Revenue as Reported	0.24	0.02	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.